Intra-Cellular Therapies, Inc v. Iancu, No. 18-1849 (Fed. Cir. Sept. 18, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Intra-Cellular Therapies, Inc. (Intra -Cellular) appeals the summary judgment decision of the United States Dis- trict Court for the Eastern District of Virginia affirming the patent term adjustment (PTA) determination made by the United States Patent and Trademark Office (Patent Of- fice). During prosecution of Intra-Cellular’s patent appli- cation, the Patent Office issued a final Office action rejecting some claims and objecting to the others .